◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Santen Pharmaceutical Co., Ltd. (4536) Financial History

Name: Santen Pharmaceutical Co., Ltd. (4536) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - General · DATA UPDATED 2026-08-11

Santen Pharmaceutical Co., Ltd. (4536) operates in the Drug Manufacturers - General industry and is headquartered in Kita, Japan with about 3,968 employees. Its market capitalization is roughly JPY 625 billion. In the fiscal year ended 2026-03-31, 4536 reported JPY 291.6B in revenue and JPY 37.4B in net income.

Santen Pharmaceutical Co., Ltd. engages in the research and development, production, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

Interactive charts & full statements →

4536 Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	JPY 291.6B	JPY 300.0B	JPY 302.0B	JPY 279.0B
Gross Profit	JPY 169.7B	JPY 171.0B	JPY 178.7B	JPY 166.1B
Operating Income (EBIT)	JPY 47.8B	JPY 46.9B	JPY 38.5B	(JPY 3.1B)
Net Income	JPY 37.4B	JPY 36.3B	JPY 26.6B	(JPY 14.9B)

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4536 Free Cash Flow History

Cash flow	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(JPY 11.9B)	(JPY 12.6B)	(JPY 12.0B)

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4536 Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	JPY 423.0B	JPY 409.3B	JPY 435.7B	JPY 421.2B	—
Total Liabilities	JPY 127.0B	JPY 124.1B	JPY 130.3B	JPY 127.9B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4536 viewer.

4536 Metric Deep Dives

Other Companies in Drug Manufacturers - General

4578 · Otsuka Holdings Co., Ltd. — $6.60 trillion
4568 · Daiichi Sankyo Company, Limited — $5.10 trillion
4503 · Astellas Pharma Inc. — $4.24 trillion
4528 · Ono Pharmaceutical Co., Ltd. — $1.14 trillion
NOVN · Novartis AG — $233 billion
1093 · CSPC Pharmaceutical Group Limited — $98 billion
GSK · GSK plc — $73 billion
4552 · JCR Pharmaceuticals Co., Ltd. — $62 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← 4534 All “0-9” companies 4538 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.